The Kinghorn Cancer Centre /ID# 221097

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Myeloproliferative neoplasms

Running trials

• Active, not recruiting

  Study of Oral Navitoclax Tablet in Combination With Oral Ruxolitinib Tablet Versus Best Available Therapy to Assess Change in Spleen Volume in Adult Participants With Relapsed/Refractory Myelofibrosis

  NCT04468984· Phase 3· AbbVie· Source